TrianglePUBLICATIONS · 15481055
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2004 Dec 15
- First author
- Kantarjian H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kantarjian H
- type
- Author
- name
- Thomas D
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Giles F
- type
- Author
- name
- Jeha S
- type
- Author
- name
- Bueso-Ramos CE
- type
- Author
- name
- Pierce S
- type
- Author
- name
- Shan J
- type
- Author
- name
- Koller C
- type
- Author
- name
- Beran M
- type
- Author
- name
- Keating M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kantarjian H
- type
- Author
- name
- Thomas D
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Giles F
- type
- Author
- name
- Jeha S
- type
- Author
- name
- Bueso-Ramos CE
- type
- Author
- name
- Pierce S
- type
- Author
- name
- Shan J
- type
- Author
- name
- Koller C
- type
- Author
- name
- Beran M
- type
- Author
- name
- Keating M
- type
- Author
- bibliography ids
- nci-bib-b32629a8a7fa4f81c2b27946
- book metadata
- content sha256
- eda35d30eeb1b923279dc0016e9003dec44683dc0f00bc6a54c1d8a4e9ba8f28
- document type
- citation
- dois
- 10.1002/cncr.20668
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15481055
- immutable id
- pubmed:15481055@eda35d30eeb1b923279dc0016e9003dec44683dc0f00bc6a54c1d8a4e9ba8f28
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 12
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 2788-801
- volume
- 101
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15481055
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- 2c1ccd37bcab74e8e4b8e865d1a67927e385d71a63e95b14f41547c66a1734d6
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2004 Dec 15
- precision
- day
- year
- 2004
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Preserved source evidence · Not medical advice